Mankind Pharma has received reaffirmation in credit rating for non-convertible debentures (Rs 4,600 crore) at ICRA AA+; Stable. The company has been assigned the rating ICRA A1+ and ICRA AA+; Stable for commercial papers (Rs 5,000 crore), non-convertible debentures (Rs 400 crore) and bank facilities (Rs 1,250 crore).
Powered by Capital Market - Live News
Click here to connect with us on WhatsApp
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Indian Oil")
 "Aurobindo Pharma, Aurobindo Pharma logo")
 "India vs Bangladesh 2nd Test, Kanpur")
 "Vodafone")
 "Corporate bond issuances fell by around 22 per cent in August, despite easing yields as issuers delayed raising funds awaiting the US Federal Reserve to start cutting interest rates from this month. money cash")
